Gut bacteria may predict immunotherapy success in melanoma patients
NCT ID NCT07428252
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether the bacteria in your gut can help predict how well immunotherapy works for advanced melanoma. Researchers collected stool and blood samples from 150 patients before and during treatment. The goal is to find links between gut microbiome patterns and treatment response or side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC MALIGNANT MELANOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Institute of Oncology Ljubljana
Ljubljana, 1000, Slovenia
More trials for these conditions
Other studies related to the condition(s) this trial covers.